NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study.

MLA

Peng, Jia, et al. “NAFLD Fibrosis Score Is Correlated with PCSK9 and Improves Outcome Prediction of PCSK9 in Patients with Chest Pain: A Cohort Study.” Lipids in Health and Disease, vol. 21, no. 1, Jan. 2022, p. 3. EBSCOhost, https://doi.org/10.1186/s12944-021-01610-w.

APA

Peng, J., Liu, M.-M., Jin, J.-L., Cao, Y.-X., Guo, Y.-L., Wu, N.-Q., Zhu, C.-G., Dong, Q., Sun, J., Xu, R.-X., & Li, J.-J. (2022). NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study. Lipids in Health and Disease, 21(1), 3. https://doi.org/10.1186/s12944-021-01610-w

Chicago

Peng, Jia, Ming-Ming Liu, Jing-Lu Jin, Ye-Xuan Cao, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, et al. 2022. “NAFLD Fibrosis Score Is Correlated with PCSK9 and Improves Outcome Prediction of PCSK9 in Patients with Chest Pain: A Cohort Study.” Lipids in Health and Disease 21 (1): 3. doi:10.1186/s12944-021-01610-w.